USP 800 The Count Down to Required Compliance

Dr. Neil Hunter, PharmaD., MBA, BCSCP, is the System Director – Sterile Drug Compounding for Ochsner Health, encompassing oversight for forty-seven hospitals. His practice expertise includes sterile compounding and healthsystem automation. His focus is to automate processes, in a system setting, which allow for a data driven approach to ensure medications are delivered safely, and in a timely manner. 

Nationally, Dr. Hunter serves on the BD Connected Medication Management and SCA Advisory Board’s. In the state of Louisiana, he serves as President-Elect for the LSHP, and as the President of the South-East LSHP local chapter. In this setting, he is an advocate for hospital pharmacist and is striving to increase Louisiana Pharmacist participation in LSHP. 

Dr. Neil Hunter, PharmaD., MBA, BCSCP, is the System Director – Sterile Drug Compounding for Ochsner Health Discusses USP 800
Dr. Neil Hunter, PharmaD., MBA, BCSCP, is the System Director – Sterile Drug Compounding for Ochsner Health Discusses USP 800

LEARNING OBJECTIVES:

• Discuss the health effects on hazardous drugs on humans
• Describe the practice standards for handling hazardous drugs in healthcare settings
• Evaluate architectural cleanroom designs before construction
• Select cleanroom products appropriate for cleanroom construction

Latest Videos
View all Videos
Executive Insights
Oct 24, 2024

Ify Igbunike, Director of Pharmacy Services at University of Maryland Midtown Campus, sat down with Pharmacy Angle to discuss value-based pharmacy practices and narcotic diversion prevention. She shares valuable insights on implementing evidence-based care, the role of behavioral assessments in managing controlled substances, and the complexities of regulatory compliance. Watch the full interview to gain expert knowledge on navigating today's healthcare challenges.

Executive Insights
Oct 10, 2024

In this insightful interview, Alex Kardos, Corporate Director of Pharmacy Services at RX Holding Hospital, discusses his role overseeing pharmaceutical operations across 126 sites. He highlights the challenges of navigating regulatory pressures, drug shortages, and staffing issues while emphasizing the growing importance of driving revenue in outpatient settings. Kardos shares how his team balances these demands by leveraging peer insights and vendor partnerships to improve efficiency and compliance.

Executive Insights
Oct 01, 2024

Dr. Rabiah Dys, Senior Vice President of Clinical Services and Program Development at CPS, shared insights at ASHP on her role and passion for advancing health equity. She emphasized the importance of improving health literacy by helping patients understand their diagnoses and care plans, starting at hospital admission. Dr. Dys also highlighted the need for better continuity of care between hospital discharge and community pharmacy settings to ensure patients can manage their health effectively.